Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...

It’s that time of year again: the dreaded cold and flu season is on the horizon. But lurking in the shadows is a more sinister threat: RSV.

Hutton DW, Prosser LA, Rose AM, et al. Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virus. Vaccine . 2024;42(24):126294. doi:10.1016/j.vaccine ...

Arexvy is approved for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older and in individuals 50 through ...

RSV, a common respiratory virus that usually causes mild, cold-like symptoms, is on the rise. While usually innocuous in adults, RSV cases in children and the elderly can be far more serious.

The truth is 80% of babies under 1 year old catch RSV. “They probably mostly catch it from other children,” said Andrew Pavia, MD, Pediatric Infectious Disease at University of Utah Health/Primary ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Pregnant women across Australia could be offered a free vaccine to protect their babies against respiratory syncytial virus (RSV) from next year. Health Minister Mark Butler has flagged the ...

Covid-19 levels in the United States are high and rising, flu season is approaching quickly, and RSV cases are already ... ahead of the respiratory virus season.” We don’t know how effective ...

COVID-19 levels in the United States are high and rising, flu season is approaching quickly, and RSV cases are already ...

(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and ...